Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Carrillo

Showing results (441-450 of 524) with videos related to

Pageof 53
Sort By:
Research Square|May 7, 2026
Uncovering the invisible giant: Amyloid beta plaques and their proposed association with waste removal in Alzheimer-affected human hippocampusRuth Fabian-Fine, Abigail G Roman, Melanie J Winters, et al.
JAMA Neurology|July 28, 2025
Concordance Between Amyloid-PET Quantification and Real-World Visual ReadsEhud Zeltzer, Daniel R Schonhaut, Nidhi S Mundada, et al.
JAMA Neurology|April 20, 2026
Brain Imaging Biomarkers and Cognitive Outcomes in a Multidomain Lifestyle Intervention: The POINTER Imaging Ancillary StudyTheresa M Harrison, Danielle J Harvey, Trevor Chadwick, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 31, 2021
The Alzheimer's Association international guidelines for handling of cerebrospinal fluid for routine clinical measurements of amyloid β and tauOskar Hansson, Richard Batrla, Britta Brix, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 26, 2011
Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseReisa A Sperling, Paul S Aisen, Laurel A Beckett, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 16, 2025
Baseline cognition and demographic, lifestyle, and cardiovascular risk factors in US POINTERKathryn V Papp, Sarah Tomaszewski Farias, Marjorie Howard, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
Uncovering the invisible giant: Amyloid ß plaques and their proposed association with waste removal in Alzheimer-affected human hippocampusRuth Fabian-Fine, Abigail G Roman, Melanie J Winters, et al.
Alzheimer'S & Dementia. Behavior & Socioeconomics of Aging|March 12, 2026
Association of residential neighborhood disadvantage with amyloid PET positivity among cognitively impaired individualsCharles C Windon, Elena Tsoy, Jennifer Livaudais-Toman, et al.
Alzheimer'S & Dementia (New York, N. Y.)|January 10, 2022
The Worldwide Alzheimer's Disease Neuroimaging Initiative: ADNI-3 updates and global perspectivesChristopher J Weber, Maria C Carrillo, William Jagust, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 17, 2020
Further understanding the connection between Alzheimer's disease and Down syndromeHeather M Snyder, Lisa J Bain, Adam M Brickman, et al.
Pageof 53

Showing results (441-450 of 524) with videos related to

Sort By:
Pageof 53
Research Square|May 7, 2026
Uncovering the invisible giant: Amyloid beta plaques and their proposed association with waste removal in Alzheimer-affected human hippocampusRuth Fabian-Fine, Abigail G Roman, Melanie J Winters, et al.
JAMA Neurology|July 28, 2025
Concordance Between Amyloid-PET Quantification and Real-World Visual ReadsEhud Zeltzer, Daniel R Schonhaut, Nidhi S Mundada, et al.
JAMA Neurology|April 20, 2026
Brain Imaging Biomarkers and Cognitive Outcomes in a Multidomain Lifestyle Intervention: The POINTER Imaging Ancillary StudyTheresa M Harrison, Danielle J Harvey, Trevor Chadwick, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 31, 2021
The Alzheimer's Association international guidelines for handling of cerebrospinal fluid for routine clinical measurements of amyloid β and tauOskar Hansson, Richard Batrla, Britta Brix, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 26, 2011
Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseReisa A Sperling, Paul S Aisen, Laurel A Beckett, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 16, 2025
Baseline cognition and demographic, lifestyle, and cardiovascular risk factors in US POINTERKathryn V Papp, Sarah Tomaszewski Farias, Marjorie Howard, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
Uncovering the invisible giant: Amyloid ß plaques and their proposed association with waste removal in Alzheimer-affected human hippocampusRuth Fabian-Fine, Abigail G Roman, Melanie J Winters, et al.
Alzheimer'S & Dementia. Behavior & Socioeconomics of Aging|March 12, 2026
Association of residential neighborhood disadvantage with amyloid PET positivity among cognitively impaired individualsCharles C Windon, Elena Tsoy, Jennifer Livaudais-Toman, et al.
Alzheimer'S & Dementia (New York, N. Y.)|January 10, 2022
The Worldwide Alzheimer's Disease Neuroimaging Initiative: ADNI-3 updates and global perspectivesChristopher J Weber, Maria C Carrillo, William Jagust, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 17, 2020
Further understanding the connection between Alzheimer's disease and Down syndromeHeather M Snyder, Lisa J Bain, Adam M Brickman, et al.
Pageof 53